Mastodawn

Two days, two landmark presentations at the #EASLCongress, two @nejm papers, and a whole lotta progress toward better therapies for #MASH with #survodutide and #tirzepatide.
HT: @danieljdrucker @boehringer @elilillyandco
https://conscienhealth.org/2024/06/survodutide-and-tirzepatide-dash-for-a-splash-with-mash/

Survodutide and Tirzepatide Dash for a Splash with MASH - ConscienHealth

These past two days brought us big news about survodutide and tirzepatide in MASH from the EASL Congress and NEJM.

ConscienHealth